| Income Statement |
| Total Revenue | 389.20M |
|
| Revenues (USD) | 389.20M |
| Cost of Revenue | 239.90M |
| Gross Profit | 149.30M |
| Operating Expenses | 114.70M |
| Research and Development Expense | 15.50M |
| Selling, General and Administrative Expense | 40.80M |
| Operating Income | 34.60M |
| Interest Expense | 4.10M |
| Income Tax Expense | 200.00K |
| Net Income | 25.40M |
| Net Income Common Stock | 24.10M |
| Net Income Common Stock (USD) | 24.10M |
| Consolidated Income | 25.40M |
| Earnings per Basic Share | 1.54 |
| Earnings per Basic Share (USD) | 1.54 |
| Earnings per Diluted Share | 1.49 |
| Earning Before Interest & Taxes (EBIT) | 29.70M |
| Earning Before Interest & Taxes (USD) | 29.70M |
| Preferred Dividends Income Statement Impact | 1.30M |
| Weighted Average Shares | 15.70M |
| Weighted Average Shares Diluted | 17.00M |
| Balance Sheet |
| Cash and Equivalents | 574.80M |
| Cash and Equivalents (USD) | 574.80M |
| Investments | 517.10M |
| Trade and Non-Trade Receivables | 442.90M |
| Total Assets | 1.67B |
| Total Debt | 197.80M |
| Total Liabilities | 1.23B |
| Accumulated Retained Earnings (Deficit) | -1.58B |
| Accumulated Other Comprehensive Income | -2.00M |
| Shareholders Equity | 327.90M |
| Shareholders Equity (USD) | 327.90M |
| Total Debt (USD) | 197.80M |
| Deferred Revenue | 384.00M |
| Trade and Non-Trade Payables | 135.50M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.70M |
| Net Cash Flow from Financing | -31.90M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -34.10M |
| Capital Expenditure | -3.70M |
| Issuance (Purchase) of Equity Shares | -20.70M |
| Issuance (Repayment) of Debt Securities | -4.40M |
| Net Cash Flow from Investing | -59.70M |
| Net Cash Flow - Investment Acquisitions and Disposals | -56.00M |
| Net Cash Flow from Operations | 57.50M |
| Share Based Compensation | 6.60M |